How the protease thrombin talks to cells

被引:502
作者
Coughlin, SR
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1073/pnas.96.20.11023
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
How does a protease act like a hormone to regulate cellular functions? The coagulation protease thrombin (EC 3.4.21.5) activates platelets and regulates the behavior of other cells by means of G protein-coupled protease-activated receptors (PARs), PAR1 is activated when thrombin binds to and cleaves its amino terminal exodomain to unmask a new receptor amino terminus. This new amino terminus then serves as a tethered peptide ligand, binding intramolecularly to the body of the receptor to effect transmembrane signaling, The irreversibility of PAR1's proteolytic activation mechanism stands in contrast to the reversible ligand binding that activates classical G protein-coupled receptors and compels special mechanisms for desensitization and resensitization, In endothelial cells and fibroblasts, activated PAR1 rapidly internalizes and then sorts to lysosomes rather than recycling to the plasma membrane as do classical G protein-coupled receptors, This trafficking behavior is critical for termination of thrombin signaling. An intracellular pool of thrombin receptors refreshes the cell surface with naive receptors, thereby maintaining thrombin responsiveness. Thus cells have evolved a trafficking solution to the signaling problem presented by PARs, Four PARs have now been identified. PAR1, PAR3, and PAR4 can all be activated by thrombin, PAR2 is activated by trypsin and by trypsin-like proteases but not by thrombin, Recent studies with knockout mice, receptor-activating peptides, and blocking antibodies are beginning to define the role of these receptors in vivo.
引用
收藏
页码:11023 / 11027
页数:5
相关论文
共 65 条
[1]   Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[2]   TRANSITION OF BOVINE TRYPSINOGEN TO A TRYPSIN-LIKE STATE UPON STRONG LIGAND-BINDING - REFINED CRYSTAL-STRUCTURES OF BOVINE TRYPSINOGEN-PANCREATIC TRYPSIN-INHIBITOR COMPLEX AND OF ITS TERNARY COMPLEX WITH ILE-VAL AT 1.9 A RESOLUTION [J].
BODE, W ;
SCHWAGER, P ;
HUBER, R .
JOURNAL OF MOLECULAR BIOLOGY, 1978, 118 (01) :99-112
[3]  
BRASS LF, 1992, J BIOL CHEM, V267, P13795
[4]   Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active [J].
Camerer, E ;
Rottingen, JA ;
Iversen, JG ;
Prydz, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29034-29042
[5]   TETHERED LIGAND LIBRARY FOR DISCOVERY OF PEPTIDE AGONISTS [J].
CHEN, J ;
BERNSTEIN, HS ;
CHEN, M ;
WANG, L ;
ISHII, M ;
TURCK, CW ;
COUGHLIN, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23398-23401
[6]  
CHEN J, 1994, J BIOL CHEM, V269, P16041
[7]   MITOGENIC ACTIVITY OF BLOOD COMPONENTS .1. THROMBIN AND PROTHROMBIN [J].
CHEN, LB ;
BUCHANAN, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (01) :131-135
[8]   THROMBIN RECEPTOR ACTIVATING PEPTIDES - IMPORTANCE OF THE N-TERMINAL SERINE AND ITS IONIZATION STATE AS JUDGED BY PH-DEPENDENCE, NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, AND CLEAVAGE BY AMINOPEPTIDASE-M [J].
COLLER, BS ;
WARD, P ;
CERUSO, M ;
SCUDDER, LE ;
SPRINGER, K ;
KUTOK, J ;
PRESTWICH, GD .
BIOCHEMISTRY, 1992, 31 (47) :11713-11720
[9]  
COLOTTA F, 1994, AM J PATHOL, V144, P975
[10]   Role of the thrombin receptor In development and evidence for a second receptor [J].
Connolly, AJ ;
Ishihara, H ;
Kahn, ML ;
Farese, RV ;
Coughlin, SR .
NATURE, 1996, 381 (6582) :516-519